ResurgentSelf covers GLP-1 programs, peptide therapy, and longevity science for adults 35+. Pick your goal below and we'll point you to exactly the right place.
You've heard about GLP-1 medications — semaglutide, tirzepatide — and want to understand if they're right for you, what they actually cost, and how to find a legitimate program without getting overcharged.
Something shifted in your mid-30s. Energy, metabolism, recovery, body composition — all changed. Start here to understand the science before pursuing any specific program.
You've heard about BPC-157, NAD+, sermorelin, and growth hormone peptides. Start here to understand what the research actually says, what's legitimate, and what to discuss with a provider.
You're not in crisis — you're planning ahead. Investing in your health now so your 50s, 60s, and beyond look very different from the default trajectory.
No problem. The best starting point for anyone new to this space is understanding what changes at 35 and why. Start there and everything else will make more sense.
Quick answers with links to the full guides.
Yes — 14 telehealth programs offer compounded semaglutide and tirzepatide with no insurance required. Starting prices range from $49–$249/month depending on the provider.
See all 14 programs →Brand-name Wegovy costs $1,349/month without insurance. Compounded semaglutide through telehealth starts at $119/month — same active ingredient, fraction of the cost. Hidden fees matter too.
See the full cost breakdown →Semaglutide targets one receptor (GLP-1). Tirzepatide targets two (GLP-1 + GIP). Tirzepatide shows stronger weight loss in trials — ~21% vs ~15% — but costs more and has a slightly different side effect profile.
Full comparison guide →The most common are nausea, fatigue, and reduced appetite — concentrated in the first 4–8 weeks. 93% of patients in clinical trials continued treatment. Most side effects resolve after the initial titration period.
Week-by-week side effect guide →Starting July 2026, eligible Medicare beneficiaries may access GLP-1 medications for weight loss — potentially for around $50/month with a qualifying Part D or MA-PD plan. Coverage, eligibility, and medications vary.
Check Medicare eligibility →We earn affiliate commissions when readers sign up for programs through our links. This is disclosed at the top of every relevant page — not buried in the footer. Commissions never influence our rankings.
Read our full disclosure →Our free 2026 GLP-1 cost guide breaks down what every major program actually charges — the real number after dose increases, hidden fees, and the price gap between brand-name and compounded. Free PDF, no credit card required.
No spam. Unsubscribe any time.
28.7% average weight loss in Phase 3 — the highest ever recorded for an obesity medication. Not FDA approved yet. Here's everything we know about the timeline and what it means.